Life Sciences Collaborations During the Pandemic

Nixon Peabody attorney Seth Levy will be presenting as part of the online conference “From Discovery to Commercialization: Valuable guidance to enhance the success of your startup.”

Companies are scrambling to collaborate on the rapid development and deployment of products and services to address the pandemic. This requires highly efficient dealmaking that enables important projects to quickly proceed, but also must account for unusual challenges in:

• obtaining access to highly sought after patient samples; 
• disruptions to R&D based on stay-home orders, supply chain limitations, and other practical constraints; and
• an evolving regulatory landscape for vaccines, therapeutics and devices.

This all must be balanced with the range of issues important in any biotech collaboration, such as the management of intellectual property and access to sufficient financial resources.

This session will provide guidance and tips to consider in navigating this challenging time, which nonetheless presents tremendous opportunity for innovation.

For more information, please visit the conference website.